EuroEyes Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend

Bulletin Express
08/14

EuroEyes International Eye Clinic Limited has scheduled a board meeting for 31 August 2026. Directors will review and approve the consolidated interim results for the six months ended 30 June 2026 and determine whether to recommend an interim dividend. Additional routine business matters may also be transacted during the session.

The Board currently consists of five executive directors—Dr. Jørn Slot Jørgensen, Mr. Jannik Jonas Slot Jørgensen, Professor Dan Zoltan Reinstein, Mr. Marcus Huascar Bracklo and Mr. Rens Laurentius Michaël Schoenmakers—along with three independent non-executive directors: Mr. Hans Helmuth Hennig, Ms. Katherine Rong Xin and Mr. Philip Duncan Wright. Rosenna Ho serves as company secretary.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10